• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28

By: AscellaHealth, LLC via GlobeNewswire
February 26, 2025 at 06:00 AM EST

BERWYN, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, reaffirms its commitment to supporting the 300 million individuals worldwide affected by rare diseases. In recognition of Rare Disease Day, held annually on the last day of February, the AscellaHealth team participates in this global initiative to raise awareness about rare diseases and highlight the strength and unity within these communities. Emphasizing the need for equitable access to care, AscellaHealth acknowledges that over 6,000 rare diseases are known, 72% of which are genetic, and 70% of genetic rare diseases begin in childhood.

"The mission of AscellaHealth is closely aligned with the goals of Rare Disease Day, placing patients at the forefront and standing in solidarity with the rare disease community,” says Dea Belazi, CEO, AscellaHealth. “Every day, our team works to advance customized clinical programs and services that support rare disease research, expedite diagnosis and treatment, and enhance therapeutic outcomes and access to novel therapies. Although rare diseases may affect smaller patient populations individually, they still impact millions and pose significant challenges to society.”

Belazi points to AscellaHealth’s end-to-end solutions that accelerate the discovery and commercialization of life-changing therapies that improve the lives of rare disease patients globally.

AscellaHealth collaborates with specialty pharmaceutical manufacturers worldwide to advance innovative research and accelerate the launch of groundbreaking cell and gene therapies (CGTs) that have the potential to cure or slow the progression of rare diseases. The Company’s expert teams also work closely with payers to explore reimbursement strategies and benefit management approaches that enhance access to high-cost treatments. Dedicated to delivering comprehensive solutions, AscellaHealth helps improve operational efficiency, broaden access and drive better outcomes for members.

In honor of Rare Disease Day, and as part of our ongoing Podcast Pulse series, AscellaHealth has produced a special podcast that showcases inspiring stories from patients who have benefited from the support of our dedicated care coordinators throughout their rare disease journey. We celebrate their strength and resilience, proudly amplifying their voices in recognition of this meaningful day.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com.


Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Primary Logo

More News

View More
Amazon Stock Rally Hits New Highs: Buy Into Earnings?
July 22, 2025
Via MarketBeat
Tickers AMZN GOOGL META
Forget the Hype—TSMC Is the AI Stock That Actually Delivers
July 22, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AAPL NVDA TSM
Why Lucid’s 36% Rally on Uber Deal Could Be a Game-Changer
July 22, 2025
Via MarketBeat
Topics Electric Vehicles
Tickers GOOG LCID TSLA UBER
Block Levels Up: What S&P 500 Inclusion Means for Investors
July 22, 2025
Via MarketBeat
Topics ETFs Stocks
Tickers XYZ
Steel Dynamics Stock Steady on Long-Term Prospects
July 22, 2025
Via MarketBeat
Topics World Trade
Tickers CLF STLD X
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap